Geneva, Feb. 13 -- International Clinical Trials Registry received information related to the study (ChiCTR2600118549) titled 'Efficacy and Safety of Saccharomyces boulardii Sachets for Preventing Antibiotic-Associated Diarrhea in Children: A Multicenter, Open-Label, Randomized Parallel-Controlled Study' on Feb. 8.

Study Type: Interventional study

Study Design: Parallel

Primary Sponsor: Shenzhen Children's Hospital

Condition: Pediatric Antibiotic-Associated Diarrhea K52.9 (antibiotic-associated diarrhea, pediatric population)

Intervention: Experimental Group:Experimental Group: Conventional therapy (including antibiotics) plus Saccharomyces boulardii sachets, for a treatment duration of 5 to 14 days. Saccharomyces boulardii sachet...